Tag | Content |
---|
EnhancerAtlas ID | HS052-00149 |
Organism | Homo sapiens |
Tissue/cell | Fibroblast_foreskin |
Coordinate | chr1:8228960-8230990 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
BHLHE40 | MA0464.2 | chr1:8229987-8229997 | ATCACGTGAC | + | 6.02 | FOS | MA0476.1 | chr1:8229534-8229545 | AATGAGTCACA | - | 6.62 | JUN(var.2) | MA0489.1 | chr1:8229530-8229544 | AGAAAATGAGTCAC | + | 6.06 | LMX1B | MA0703.2 | chr1:8230084-8230095 | AATTTAATTAA | + | 6.32 | MITF | MA0620.2 | chr1:8229983-8230001 | AAAGATCACGTGACCACA | + | 6.84 | MITF | MA0620.2 | chr1:8229983-8230001 | AAAGATCACGTGACCACA | - | 6.84 | PHOX2A | MA0713.1 | chr1:8229479-8229490 | TAATCTAATTA | + | 6.32 | PROP1 | MA0715.1 | chr1:8229479-8229490 | TAATCTAATTA | + | 6.14 | Phox2b | MA0681.1 | chr1:8229479-8229490 | TAATCTAATTA | + | 6.32 | TFEB | MA0692.1 | chr1:8229987-8229997 | ATCACGTGAC | + | 6.02 | USF2 | MA0526.2 | chr1:8229985-8230001 | AGATCACGTGACCACA | - | 6.53 | ZNF263 | MA0528.1 | chr1:8229867-8229888 | AAAGGAGAGGGAAGAGAGAGA | + | 6.14 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_33918 | chr1:8229333-8230616 | HCC1954 | SE_34231 | chr1:8224429-8231079 | HCT-116 | SE_47106 | chr1:8229101-8231021 | Panc1 | SE_55963 | chr1:8229122-8230767 | u87 | SE_65889 | chr1:8229106-8231055 | Pancreatic_islets |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr1 | 8230370 | 8230423 | chr1 | 8229400 | 8230949 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I008168 | chr1 | 8228915 | 8230994 |
|
Enhancer Sequence | TCTCAAACAA AAACAAAAAC AAAAATGAGC CGGGTGTGGT GGCACATGCC TGTAATCCCA 60 GCTATTTGGG AGGCTGAGTG GGGAGAATCA CTTGAACCTG GGAGGCAGAG GTTGCAGTGA 120 GCCAAGATCA CACCACTGCA CTCCAGCCCG GCCAATAAGA GTAAAACTCC GTCTCAAAAA 180 AATAAAAAAC AAGAAAAACC TAGGATGGGC CGGGCATGGT GGCTCATGCC TGTAATCCCA 240 GCACTTTGGG AGGCCGAGGC AGGGGGATCA CTTGAGGTCA AGAGTTTGAC ACCAGCCTGG 300 CCAACATGGT AAAACCCCAC CTCTACTAAA AATACAAAAA TTAGCTGGAC ATGGTAGCAG 360 GTGTCTGTAA TACTAGCTAC TCAGGAGGCT AGGGCAGGAG CATCACTTGA ACCTGGGAGG 420 TGAAGTTTGC AGCTAGCCAA GATCGCGCCA CTGCACTCCA GCCTGGGCCG CAACAACAGC 480 AACAACAAAA TACCTAGGAT GCAGCACTCT TCATGGATTT AATCTAATTA TCATGTGAGA 540 TGAGTCAATG ATCATGAATT GTAGGGGTAA AGAAAATGAG TCACAATGAG ACCATTGGTG 600 ATGGGTCAGA AGGGGCTCCC TGGTTTCACC CTCCACTGCC CTGGGGGGTC CACGCTTCCC 660 CTTGAGCTGT GGCTGGGTGA TGCTGCCCTC AAAGGCCAGC TGTCATGGGC TTTCCCCACC 720 CCGACCCTGA AATTTCCCCC ATTTGTCTGA GCTATGGCCA CCTTACTGGC TCAGAAGTCA 780 GGCTACAATA CTGCAATGGA ACCGGGTGAT GAAGTGTCAT AAATAGTTAA TACAAATTCT 840 GCCAACAAGT TTGGGGTTAA TAGCCGATCT TAAAATGGGT AAGGGAAAGA AAGGGAGAGG 900 GAGGGAAAAA GGAGAGGGAA GAGAGAGAGA GACAAAGAAA AAGAGAGAGA TTTTCTGGCA 960 TTCATCCTAA GCATTTCAGC CGTAAACTGG TTTAGGCCAG TGAGACAGGA TGTTCTGCAG 1020 AGCAAAGATC ACGTGACCAC ACAGTGCGAA CAAACAGATG GTGTATCATT AACAAACTGC 1080 AACGCTGCAT TTCCTAGTCT CTCCAGGGTG TCAGTGACCC AGGCAATTTA ATTAAAAACA 1140 TTAAAAAAAA AAAAAAAAGT GACAAGGGCC AAAGTTTCAT CCTGTTTAAA TTCAACTTCA 1200 TCAAAAAAGT GGAGGGGCTA TCCCTTCCAT GAAACGTCCA CATATGAGCC CCTCAGGGAA 1260 GTGGCACCAA CGTGTAGGTC AGTGGCACAG TCAGGCCTCT GGTCAGTGGC CATTGATCCA 1320 GAAATGCGGC CAGGGCATGG CCAGGGCAGG GGCAGCTCCA GGACAGAGAC CAGCTCGCCT 1380 CCCATTAGCC TCCTGGGGAG ACAGGACAGG TAAACAGCAG GGAGCTCAGG GGGTTTTATG 1440 GACCAGGCCG TGTACACAGT TTGTCCCGAG TACAAACAAG CAGGTGGCCA GTCTCACCTT 1500 TGTTCTAAGA AGCGGGATCC AGGCAGGCCA GGAGGCCCAG AGGGTAGCTG TCAGGAGACA 1560 CTGGGGCCCA ACCAGGGCTT CCCACTGCAG GAGCGGGTCA GGAGCTTGGA CACTCTCGGA 1620 CACTCAGCAC TGTCCTCGCT TGAACCTCCC CGGTAATGGC AGCATAAAGT GATGGTCAAG 1680 GGGCATCCGG TTGGGACTCA AGAAGCTTAA TCCCAAATCC CTGCCCCACA GTCTACCAGT 1740 GACAGACACT GTGCTGAAGT CAGCCTCCAC ATGCTCACCT GTAGAATTGT GACAACATGG 1800 CAAGGGCAGG TGAAGGCCCC AGGATAGTGC CTGGCCATTG AGAGTGCTCT GTCGTGCAGG 1860 TGGGCATGGG CATGGGGCTG TCCAGAATTG AGCTGTTTTT TTGAGTTGGA GTCTTGCTCT 1920 GTAGCCCAGG CTGGAGTGCA ATGGTTCACT GCAACCTCTG CCTCCCAGGT TCACGTGATT 1980 CTCCTGCCTC AGCCTCCCGA GTAGCTGGGA TTACAGGTGA CCAACACCAC 2030
|